Atherosclerosis NewsNews on Atherosclerosis continually updated from thousands of sources around the net.New non-invasive CT scan may detect early signs of heart disease- May 31, 2008 Washington, May 30: Scientists have developed a new non-invasive technique that may prove effective in uncovering early signs of heart disease.http://www.topix.net/health/atherosclerosis/2008/05/new-non-invasive-ct-scan-may-detect-ea... Medical News & Perspectives: Cholesterol Drug Controversy Continues- May 25, 2008 Controversy over the use of ezetimibesimvastatin to prevent progression of atherosclerosis continues to grow.http://www.topix.net/health/atherosclerosis/2008/05/medical-news-perspectives-cholesterol-... Succinobucol yields mixed effects in patients with acute coronary syndromes- May 23, 2008 Treatment with the antioxidant succinobucol appears to have both beneficial and harmful effects in patients with a history of myocardial infarction or unstable angina, according to a report in the May 24th ...http://www.topix.net/health/atherosclerosis/2008/05/succinobucol-yields-mixed-effects-in-p... Controlling Cholesterol with Statins- May 21, 2008 Too much cholesterol can increase a person's chance of getting cardiovascular disease.http://www.topix.net/health/atherosclerosis/2008/05/controlling-cholesterol-with-statins?f... Schering Glitters, But Is It Gold- May 19, 2008 "I think everybody knows that, including my 11-year-old son" This morning, on Schering-Plough 's first-quarter earnings conference call, Schering Chief Executive Fred Hassan reminded the drug industry why it fell in love with him in the first place. via Forbeshttp://www.topix.net/health/atherosclerosis/2008/05/schering-glitters-but-is-it-gold?fromr... Cerenis Therapeutics reports positive Phase 1 data for HDL drug- May 17, 2008 "The completion of our first clinical trial represents an important milestone for Cerenis, further validating our promising technology platform and our expanding library of investigational compounds to treat atherosclerosis" Ann Arbor-based Cerenis Therapeutics is reporting "strong efficacy" in raising the so-called good HDL cholesterol during a Phase 1 clinical trial for one of its drug candidates. via Ann Arbor Newshttp://www.topix.net/health/atherosclerosis/2008/05/cerenis-therapeutics-reports-positive-... Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for...- May 15, 2008 CER-002 is a peroxisome proliferator-activated receptor delta-specific agonist in development for the treatment of cardiovascular diseases. via Rehab Managementhttp://www.topix.net/health/atherosclerosis/2008/05/cerenis-therapeutics-completes-phase-i... Expanded Class Action Lawsuit Filed Against Merck and Co Inc.- May 10, 2008 Labaton Sucharow LLP filed a class action lawsuit on May 5, 2008 in the United States District Court for the District of New Jersey, on behalf of purchasers of the securities of Merck & Co., Inc. via LawFuel.comhttp://www.topix.net/health/atherosclerosis/2008/05/expanded-class-action-lawsuit-filed-ag... Article Torcetrapib Does Not Reduce Atherosclerosis Beyond...- May 8, 2008 Jitske de Vries-van der Weij MSc, Jos W.A. van der Hoorn MSc, Thomas Gautier PhD, Caroline C. van der Hoogt PhD, Marit Westerterp PhD, Johannes A. Romijn PhD, MD, J. Wouter Jukema PhD, MD, Louis M. Havekes PhD, ... via Circulationhttp://www.topix.net/health/atherosclerosis/2008/05/article-torcetrapib-does-not-reduce-at... Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca- May 6, 2008 Volcano Corporation , a leading manufacturer and developer of intravascular ultrasound , functional measurement and Optical Coherence Tomography products designed to enhance the diagnosis and treatment of ... via Freshnewshttp://www.topix.net/health/atherosclerosis/2008/05/volcano-announces-participation-in-sat... |